Curaleaf Holdings (CURLF) Non Operating Investment Income (2020 - 2021)

Curaleaf Holdings (CURLF) posted quarterly Non Operating Investment Income of -$2.8 million for Q4 2021, down 110.41% year-on-year from $27.0 million in Q4 2020, and down 110.41% on a QoQ basis from $27.0 million in Q4 2020.

Curaleaf Holdings (CURLF) Non Operating Investment Income (2020 - 2021) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Non Operating Investment Income for 2 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Curaleaf Holdings 6.95 Bn 6.95 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -2.81 Mn
Dec 31, 2021 -2.81 Mn
Dec 31, 2020 26.95 Mn
Dec 31, 2020 26.95 Mn
Sep 30, 2020 10.61 Mn
Sep 30, 2020 10.61 Mn